160 related articles for article (PubMed ID: 32255545)
1. Application of curcumin and its derivatives in tumor multidrug resistance.
Xu T; Guo P; He Y; Pi C; Wang Y; Feng X; Hou Y; Jiang Q; Zhao L; Wei Y
Phytother Res; 2020 Oct; 34(10):2438-2458. PubMed ID: 32255545
[TBL] [Abstract][Full Text] [Related]
2. Curcumin effect on cancer cells' multidrug resistance: An update.
Keyvani-Ghamsari S; Khorsandi K; Gul A
Phytother Res; 2020 Oct; 34(10):2534-2556. PubMed ID: 32307747
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer.
Attia YM; El-Kersh DM; Ammar RA; Adel A; Khalil A; Walid H; Eskander K; Hamdy M; Reda N; Mohsen NE; Al-Toukhy GM; Mansour MT; Elmazar MM
Chem Biol Interact; 2020 Jan; 315():108865. PubMed ID: 31628941
[TBL] [Abstract][Full Text] [Related]
4. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
[TBL] [Abstract][Full Text] [Related]
5. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
[TBL] [Abstract][Full Text] [Related]
6. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
Choi BH; Kim CG; Lim Y; Shin SY; Lee YH
Cancer Lett; 2008 Jan; 259(1):111-8. PubMed ID: 18006147
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded PLGA nanoparticles conjugated with anti- P-glycoprotein antibody to overcome multidrug resistance.
Punfa W; Suzuki S; Pitchakarn P; Yodkeeree S; Naiki T; Takahashi S; Limtrakul P
Asian Pac J Cancer Prev; 2014; 15(21):9249-58. PubMed ID: 25422208
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line.
Zhang C; He LJ; Ye HZ; Liu DF; Zhu YB; Miao DD; Zhang SP; Chen YY; Jia YW; Shen J; Liu XP
Mol Med Rep; 2018 Dec; 18(6):5409-5416. PubMed ID: 30365132
[TBL] [Abstract][Full Text] [Related]
10. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
Wang J; Ma W; Tu P
Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanoassemblies entrapping curcumin overcome multidrug resistance in ovarian cancer.
Gou Q; Liu L; Wang C; Wu Q; Sun L; Yang X; Xie Y; Li P; Gong C
Colloids Surf B Biointerfaces; 2015 Feb; 126():26-34. PubMed ID: 25543980
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of curcumin mimics with multidrug resistance reversal activities.
Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S
Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490
[TBL] [Abstract][Full Text] [Related]
14. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
15. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
16. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer.
Gu Y; Li J; Li Y; Song L; Li D; Peng L; Wan Y; Hua S
Int J Nanomedicine; 2016; 11():5757-5770. PubMed ID: 27843316
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic activities of Carthami Flos and its reversal effect on multidrug resistance in cancer cells.
Wu JY; Yu ZL; Fong WF; Shi YQ
Afr J Tradit Complement Altern Med; 2013; 10(4):36-40. PubMed ID: 24146498
[TBL] [Abstract][Full Text] [Related]
18. Curcumin as chemosensitizer.
Limtrakul P
Adv Exp Med Biol; 2007; 595():269-300. PubMed ID: 17569216
[TBL] [Abstract][Full Text] [Related]
19. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
20. New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.
Dinic J; Podolski-Renic A; Stankovic T; Bankovic J; Pesic M
Curr Pharm Des; 2015; 21(38):5589-604. PubMed ID: 26429711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
